Clinical trial

Sitagliptin Cardiovascular Outcomes Study (MK-0431-082)

NCT00790205

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-12-10

PhasePHASE3

Study timeline

Study start (actual)2008-12-10Date precision: day

Registry last updated2021-11-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetes Mellitusunresolved

Interventions

SitagliptinDRUG · verified · RxNorm: sitagliptin

PlaceboDRUG

Sponsors & collaborators

Merck Sharp & Dohme LLClead sponsor

Duke Clinical Research Institute, Oxford Diabetes Trials Unitcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00790205 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.